News

AllAfrica on MSN2h
Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To Action
New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
The Kenya Times on MSN2h
WHO Awards Uhuru Kenyatta for Championing Pandemic Agreement
Former President Uhuru Kenyatta has received an award from the World Health Organization (WHO). WHO formally recognized the ...
Citizen Digital3h
Kenya among countries set to roll out HIV preventive drug Lenacapavir
The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...
Devdiscourse4h
WHO Endorses Lenacapavir for Twice-Yearly HIV Prevention in Landmark Update
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
14 million children did not receive a single vaccine in 2024, UN estimates
U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year.
News80008h
The world has hit a ‘very stubborn glass ceiling’ on childhood vaccination
An estimated 14.3 million children globally remain completely unvaccinated, according to a new report, and public health ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool in their efforts to fight HIV infections – especially for groups most at ...